Effects of curcumin derivatives on EGFR in gefitinib-insensitive cells. The gefitinib-insensitive lung adenocarcinoma cell lines were pre-treated with 10 μM compound, 1–37 as indicated, for 1 h prior to stimulation for 30 min with 20 ng/mL EGF. Cell lysates from (A) CL1-5 carrying wild-type EGFR, or (B) H1975 carrying L858R and T790M double mutations on EGFR, were analyzed by Western blot using antibodies to Tyr1068-phosphorylated EGFR (pEGFR), pan-EGFR (EGFR), and β-actin as a loading control.